These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party. El-Najjar I; Boumendil A; Luan JJ; Bouabdallah R; Thomson K; Mohty M; Colombat P; Biron P; Tilly H; Pfreundschuh M; Cordonnier C; Sureda A; Cahn JY; Vernant JP; Gribben J; Cook G; Haynes AP; Ferrant A; Finel H; Montoto S; Dreger P; Ann Oncol; 2014 Nov; 25(11):2224-2229. PubMed ID: 25193988 [TBL] [Abstract][Full Text] [Related]
4. Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation. Metzner B; Müller TH; Gebauer W; Casper J; Kraemer D; Rosien B; Schumann-Binarsch S; Thole R; Köhne CH; Dreyling M; Hoster E; Pott C Ann Hematol; 2014 May; 93(5):803-10. PubMed ID: 24337447 [TBL] [Abstract][Full Text] [Related]
5. Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant? Seyfarth B; Kuse R; Sonnen R; Glass B; Schmitz N; Dreger P Ann Hematol; 2001 Jul; 80(7):398-405. PubMed ID: 11529465 [TBL] [Abstract][Full Text] [Related]
6. Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure. Kothari J; Peggs KS; Bird A; Thomson KJ; Morris E; Virchis AE; Lambert J; Goldstone AH; Linch DC; Ardeshna KM Br J Haematol; 2014 May; 165(3):334-40. PubMed ID: 24438080 [TBL] [Abstract][Full Text] [Related]
7. Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis. Wang B; Ren C; Zhang W; Ma X; Xia B; Sheng Z Hematol Oncol; 2013 Mar; 31(1):29-33. PubMed ID: 22488650 [TBL] [Abstract][Full Text] [Related]
8. Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score. Peters AC; Duan Q; Russell JA; Duggan P; Owen C; Stewart DA Leuk Lymphoma; 2011 Nov; 52(11):2124-9. PubMed ID: 21740097 [TBL] [Abstract][Full Text] [Related]
9. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group. Arranz R; Conde E; Grande C; Mateos MV; Gandarillas M; Albo C; Lahuerta JJ; Fernández-Rañada JM; Hernández MT; Alonso N; García Vela JA; Garzón S; Rodríguez J; Caballero D; Eur J Haematol; 2008 Mar; 80(3):227-35. PubMed ID: 18088400 [TBL] [Abstract][Full Text] [Related]
10. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N Cochrane Database Syst Rev; 2012 Jan; 1(1):CD007678. PubMed ID: 22258971 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation. Metzner B; Müller TH; Casper J; Kimmich C; Köhne CH; Petershofen E; Renzelmann A; Thole R; Voss A; Dreyling M; Hoster E; Klapper W; Pott C Eur J Haematol; 2023 Aug; 111(2):220-228. PubMed ID: 37094812 [TBL] [Abstract][Full Text] [Related]
12. Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma. Stewart DA; Bahlis N; Valentine K; Balogh A; Savoie L; Morris DG; Jones A; Brown C; Russell JA Blood; 2006 Jun; 107(12):4623-7. PubMed ID: 16467197 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. Berglund A; Enblad G; Carlson K; Glimelius B; Hagberg H Eur J Haematol; 2000 Jul; 65(1):17-22. PubMed ID: 10914935 [TBL] [Abstract][Full Text] [Related]
14. Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma. Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL Cancer; 2008 Nov; 113(9):2496-503. PubMed ID: 18833583 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party. Bento L; Boumendil A; Finel H; Le Gouill S; Amorim S; Monjanel H; Bouabdallah R; Bay JO; Nicolas-Virelizier E; McQuaker G; Rossi G; Johnson R; Huynh A; Ceballos P; Rambaldi A; Bachy E; Malladi R; Orchard K; Pohlreich D; Tilly H; Bonifazi F; Poiré X; Guilhot F; Haenel A; Crawley C; Metzner B; Gribben J; Russell NH; Damaj G; Thomson K; Dreger P; Montoto S Bone Marrow Transplant; 2017 Aug; 52(8):1120-1125. PubMed ID: 28530668 [TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group. Colombat P; Lemevel A; Bertrand P; Delwail V; Rachieru P; Brion A; Berthou C; Bay JO; Delepine R; Desablens B; Camilleri-Broët S; Linassier C; Lamy T Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691 [TBL] [Abstract][Full Text] [Related]